The research team surveyed 384 male workers from a large aluminum plant in Shanxi Province between July and August 2024. Each participant provided fasting blood samples, from which the investigators measured fasting plasma glucose alongside the plasma concentrations of eight metals. Abnormally elevated blood glucose was defined according to World Health Organization diagnostic criteria as a fasting plasma glucose of at least 6.1 millimoles per liter, a threshold that captures both frank diabetes and the high-risk zone immediately beneath it. Because occupational cohorts are rarely uniform, the researchers also collected information on potential confounders, including age, body mass index, smoking, alcohol consumption, and other lifestyle and workplace characteristics, so that the statistical models could separate the metal signal from the noise of everyday habits and working conditions.

What makes this study technically interesting is not simply that it measured metals, but how it interrogated the mixture. Environmental epidemiology has long struggled with the problem of co-exposure: workers inhaling aluminum-laden dust are simultaneously exposed to a shifting ensemble of other elements, and the traditional one-metal-at-a-time analysis can miss both the joint effect and the individual contributions within it. The Shanxi team therefore deployed a battery of complementary statistical tools. Logistic regression provided the conventional single-metal estimates. Restricted cubic splines mapped the shape of each dose-response relationship without forcing it into a straight line. Least absolute shrinkage and selection operator regression, a machine-learning technique that penalizes weak predictors to zero, identified which metals mattered most. Weighted quantile sum regression estimated the overall mixture effect and apportioned it into weights for each component. Finally, Bayesian kernel machine regression modeled the mixture nonparametrically and probed for interactions between metals.

The single-metal results were striking. After adjustment for confounders, workers in the highest quartile of plasma aluminum had nearly three times the odds of abnormal fasting glucose compared with those in the lowest quartile, with an adjusted odds ratio of 2.93 and a 95 percent confidence interval of 1.16 to 7.40. Copper told a similar story: the top quartile carried an adjusted odds ratio of 2.71 (95 percent CI 1.17 to 6.27) relative to the bottom. Selenium, an element more often discussed as a protective micronutrient, was also implicated, with the highest quartile showing an odds ratio of 2.30 (95 percent CI 1.05 to 5.05). Restricted cubic spline analyses reinforced these findings, indicating positive and approximately linear dose-response relationships across the observed concentration ranges for all three metals, meaning the risk climbed steadily rather than appearing only at some threshold.

When the methods turned to the mixture as a whole, the picture sharpened rather than blurred. LASSO regression independently selected aluminum, selenium, and copper as the key metals in the panel, discarding the others as redundant. Weighted quantile sum regression then revealed a positive overall association between the mixed metal burden and abnormal blood glucose, and within that mixture aluminum contributed the largest share, with a weight of 0.434, followed closely by selenium at 0.375. In other words, roughly four-fifths of the mixture’s statistical weight in the model was carried by just two elements, one an unavoidable occupational exposure in an aluminum plant and the other an essential trace element whose excess appears anything but benign. Bayesian kernel machine regression confirmed positive exposure-response trends for the individual metals while finding no strong evidence of interactions, suggesting the metals act largely in parallel rather than amplifying one another.

The biology behind these associations is a subject of active research, and the study’s authors situate their findings within a substantial mechanistic literature. Oxidative stress is a central theme. Excess copper can catalyze the formation of reactive oxygen species, and laboratory work has shown that copper can mediate hydrogen peroxide production from the amylin peptide, a process proposed to contribute to the degeneration of insulin-producing islet cells in type 2 diabetes. Selenium presents a more paradoxical case. It is an essential component of antioxidant enzymes, yet several human studies, including randomized supplementation trials and dose-response meta-analyses, have linked higher selenium status to an increased risk of type 2 diabetes, and animal work has shown that high selenium can impair hepatic insulin sensitivity through dysregulated reactive oxygen species signaling. Aluminum, meanwhile, has been repeatedly associated in occupational cohorts with cognitive and metabolic disturbances, and earlier longitudinal work in northern China linked occupational aluminum exposure to changes in both blood pressure and blood glucose.

Context matters for interpreting the magnitude of the risk. Diabetes has become one of China’s defining health challenges, with epidemiological analyses in Nature Metabolism describing the scale of the epidemic and the Global Burden of Disease study projecting continued growth in prevalence through mid-century. Against that backdrop, identifying modifiable environmental contributors is a public health priority. Occupational cohorts are especially informative because exposure levels can be far above those seen in the general population, and because they can be reduced through engineering controls, personal protection, and workplace surveillance. The authors argue that their results justify targeted strengthening of occupational health protection in aluminum smelting, a recommendation that echoes earlier findings from the same research group on cognitive dysfunction among aluminum-exposed workers, where blood glucose itself appeared to mediate part of the effect of aluminum on cognition.

The study’s design imposes important caveats. It is cross-sectional, meaning metals and glucose were measured at the same time, so it cannot establish whether the metal exposures caused the metabolic disturbance or whether some shared factor, such as diet, kidney function, or disease-related changes in metal handling, drives the association. Reverse causation is a genuine possibility in trace element epidemiology, since impaired glucose metabolism can alter the transport and excretion of metals. The cohort was also limited to male workers at a single plant, which strengthens internal comparability but limits generalizability to women, to other industries, and to the wider population. Confidence intervals, while excluding the null, are wide for some estimates, reflecting the moderate sample size. The authors declare no competing financial interests, and the study was approved by the Medical Ethics Committee of Shanxi Medical University with written informed consent from all participants, but the data contain sensitive personal information and are available only from the corresponding author.

Even with those limitations, the methodological rigor of the mixture approach gives the findings unusual weight for a single cross-sectional study. Four independent techniques converged on the same trio of metals, and the dose-response curves were consistent with a monotonic relationship rather than a statistical fluke at one end of the distribution. For occupational physicians, the practical message is that glucose screening may deserve a place alongside the neurological and respiratory monitoring already routine in smelters, and that biomonitoring of aluminum, selenium, and copper could help identify workers whose cumulative metal burden places them at metabolic risk. For the broader field of environmental health, the study adds to a growing consensus that human exposure is inherently multi-element and that the health effects of any single metal can only be understood in the context of the mixture that accompanies it. As aluminum remains indispensable to transport, construction, and the renewable energy transition, the challenge is to keep the benefits of the metal while limiting its metabolic costs to the people who make it.

Subject of Research: Mixed metal exposure and abnormal fasting blood glucose among aluminum factory workers

Article Title: The association between mixed exposure to multiple metals and the risk of abnormally elevated blood glucose among aluminum factory workers

Article References: Zhang, Y., Xin, Y., Li, M., Xu, H., Guo, X., Wang, L., Zhang, H., Yin, J., Lu, X., Pan, B., & Song, J. (2026). The association between mixed exposure to multiple metals and the risk of abnormally elevated blood glucose among aluminum factory workers. Environmental Geochemistry and Health, 48(14), Article 564. https://doi.org/10.1007/s10653-026-03460-w

Image Credits: AI Generated

DOI: 10.1007/s10653-026-03460-w

Keywords: aluminum, selenium, copper, heavy metals, blood glucose, occupational health, aluminum smelting, metal mixture, diabetes risk, Bayesian kernel machine regression, weighted quantile sum regression, Shanxi

The central methodological innovation of the work lies in its treatment of exposure. Most earlier studies examined metals one at a time, an approach that obscures the reality that people are exposed to complex cocktails of elements simultaneously through air, food, water, and consumer products. To address this, the research team, led by Maoling Fu of Hunan University of Medicine together with colleagues at Tongji Hospital and the PLA General Hospital, deployed four complementary analytical strategies: conventional logistic regression for individual metals, weighted quantile sum regression, quantile-based g-computation, and Bayesian kernel machine regression, commonly abbreviated as BKMR. Each of the mixture methods weighs the relative contribution of every component metal to the overall effect, allowing the researchers to identify which elements drive the association and whether the combined effect is greater than the sum of its parts.

The single-metal results already revealed a consistent pattern. Blood concentrations of cadmium, lead, and manganese were each significantly associated with obesity risk, as were urinary concentrations of cadmium, lead, cobalt, cesium, antimony, and tungsten. Cadmium and lead are classic toxic heavy metals with no physiological function, while manganese is an essential trace element that becomes harmful at excessive levels. The appearance of manganese as a significant player is particularly noteworthy because the element is required for normal brain development and enzyme function, yet disturbances of manganese homeostasis have been linked in prior research to neurotoxicity and, in animal studies, to mitochondrial damage in liver tissue. A previous population-based study had also reported associations between blood manganese levels and visceral adipose tissue in adults, lending plausibility to the new pediatric findings.

When the metals were analyzed as mixtures, the blood results pointed in one clear direction. All three mixture methods, weighted quantile sum regression, quantile-based g-computation, and Bayesian kernel machine regression, converged on a significant positive association between the blood metal mixture and obesity risk, meaning that children with higher overall burdens of these circulating metals were more likely to be obese. Within that mixture, manganese emerged as the metal with the strongest contribution. This convergence across statistically distinct approaches matters because each model makes different assumptions about how mixture components interact; agreement among them substantially strengthens confidence that the observed association is not an artifact of any single modeling choice.

The urinary findings, by contrast, ran in the opposite direction. The urinary metal mixture was significantly negatively associated with obesity risk, with cadmium, lead, and cobalt showing the strongest negative contributions. At first glance this seems paradoxical: how can the same metals be positively associated with obesity when measured in blood and negatively associated when measured in urine? The authors and the broader literature suggest several possible explanations. Urinary metal concentrations reflect both exposure and excretion, and dilution effects may play a role, since obese individuals can differ in hydration status and renal function. Alternatively, the negative urinary association may reflect differences in how the body handles these metals, with obese children excreting them more efficiently, or it may indicate reverse causation, in which obesity-related physiological changes alter metal kinetics rather than metals driving obesity.

Stratified analyses added another layer of complexity. The associations between metal exposure and obesity risk were particularly pronounced among male children, suggesting that sex may modify the relationship between metal burdens and adiposity. Sex differences in body composition are well documented in pediatric populations, with boys and girls differing in visceral, subcutaneous, and total body fat distribution, and sex hormones and growth hormone axis activity are known to influence energy balance. Biological plausibility for sex-specific metal effects also exists: experimental work has shown, for example, that subacute cadmium exposure produces different metabolic changes in female rats, and cobalt treatment alters lipid metabolism in white adipose tissue in diet-induced obesity models. The new findings hint that such sex-dependent mechanisms may operate in humans as well.

The biological pathways by which heavy metals could promote obesity are an active area of investigation. Cadmium has been shown in cell studies to inhibit the differentiation of preadipocytes through the C/EBPα and PPARγ pathways, key regulators of fat cell formation, and white adipose tissue itself has been identified as a target organ for cadmium toxicity. Lead intoxication is known to disrupt endocrine function, and both cadmium and lead have been linked to obesity in adult populations in studies from Korea, China, and the United States. Manganese, meanwhile, may act through oxidative stress and through effects on the hypothalamic-pituitary-adrenal axis, a central regulator of appetite and energy balance. Oxidative stress, the imbalance between reactive oxygen species and antioxidant defenses, is a recognized consequence of redox-active metals and has been correlated with intra-abdominal fat in obese males, providing a plausible mechanistic bridge between metal exposure and fat accumulation.

The study builds on a growing body of environmental epidemiology that treats obesity not solely as a consequence of diet and physical inactivity but as a condition influenced by the chemical environment. Earlier analyses of NHANES data in adults found that cumulative exposure to heavy metal mixtures was associated with obesity and its comorbidities, and a systematic review and meta-analysis published in 2024 concluded that heavy metal exposure is associated with obesity more broadly. Pediatric evidence had been thinner, however, with some prior studies of urinary metals in children reporting mixed results. By combining a recent survey window with multiple mixture models and stratification by sex and age, the new analysis offers one of the most comprehensive pictures to date of how the metal exposome relates to childhood adiposity, and the authors note that this is the first use of multiple statistical models to confirm the combined effects of metal mixtures on childhood obesity.

Several caveats temper the conclusions. As a cross-sectional study, the analysis captures a snapshot in time and cannot establish whether metal exposure preceded the development of obesity; reverse causation remains a genuine possibility, particularly for the counterintuitive urinary findings. Measurement of metals in single blood and urine samples also provides only an estimate of longer-term exposure, and unmeasured confounders ranging from diet quality to socioeconomic circumstances could influence both metal burdens and body weight. The authors themselves are explicit that further research is needed to confirm the findings, ideally through longitudinal cohorts that track metal exposure and weight change over time in the same children.

Nevertheless, the implications are significant for public health. Childhood obesity substantially increases the risk of cardiovascular disease, type 2 diabetes, and psychosocial difficulties, and interventions that reduce environmental metal exposure, through cleaner air and water, safer consumer products, and reduced industrial emissions, are already proven public health wins for other reasons. If the associations observed here are confirmed causally, the same measures could carry an added benefit for metabolic health in children, particularly boys who appear most vulnerable. The study also highlights the value of mixture-based epidemiology: in the real world, no child is exposed to a single metal in isolation, and understanding how cadmium, lead, manganese, cobalt, and their chemical neighbors act together may be essential to grasping, and ultimately preventing, the environmental roots of the obesity epidemic.

Subject of Research: Associations between blood and urinary heavy metal exposure and childhood obesity risk in the U.S. NHANES 2015-2020 population

Article Title: Associations of blood and urinary heavy metals with obesity risk among children: NHANES 2015-2020

Article References: Fu, M., Xiang, Y., Li, X., & Wang, R. (2026). Associations of blood and urinary heavy metals with obesity risk among children: NHANES 2015-2020. Pediatric Research. https://doi.org/10.1038/s41390-026-05488-1

Image Credits: AI Generated

DOI: 10.1038/s41390-026-05488-1

Keywords: childhood obesity, heavy metals, cadmium, lead, manganese, cobalt, NHANES, metal mixtures, Bayesian kernel machine regression, environmental epidemiology, pediatric health, obesity risk

The research, led by a team at Beijing Children’s Hospital of Capital Medical University, analyzed data from 257 pediatric patients treated with sirolimus, drawing on a remarkable 766 to 892 blood samples collected during routine care. Rather than treating adverse reactions as isolated events, the investigators systematically quantified the relationship between steady-state trough concentrations of sirolimus, known as Cmin, and three of the drug’s most clinically significant toxicities: myelosuppression, abnormal liver function, and dyslipidemia. Trough concentrations, measured immediately before the next dose, are the standard metric for therapeutic drug monitoring of sirolimus, because the drug’s effects and toxicities track closely with whole-blood levels.

What makes the study methodologically distinctive is its pairing of two computational approaches that rarely meet in pharmacology. The first is Bayesian kernel machine regression, or BKMR, a flexible statistical framework originally developed to assess the health effects of complex environmental exposures such as air pollutant mixtures. BKMR excels at modeling nonlinear relationships and interactions among multiple simultaneous exposures without imposing rigid functional forms, which makes it well suited to the messy reality of pediatric drug monitoring, where age, weight, disease type, concomitant medications, and treatment duration all shift the toxicity landscape. The second component is a population pharmacokinetic model, or PopPK, which describes how sirolimus is absorbed, distributed, and cleared across a heterogeneous population of children and predicts individual exposure from dosing history and patient characteristics.

By integrating the two into a unified BKMR-PopPK framework, the researchers created something more powerful than either method alone. The PopPK model translates a proposed dose into a predicted trough concentration for a specific child, while the BKMR layer converts that predicted exposure into a quantified risk of myelosuppression, liver injury, or dyslipidemia. The result is a tool for model-informed precision dosing, an approach that replaces one-size-fits-all weight-based dosing with individualized regimens designed to keep each patient inside a safety window that is narrow enough to prevent toxicity but wide enough to control the underlying vascular lesion.

The analysis identified disease complexity and duration of therapy as key modifiers of risk. Children with complex or mixed vascular malformations faced different exposure-response relationships than those with simpler, more localized lesions, and the risks of certain toxicities grew as treatment extended over months. Based on these quantitative relationships, the team recommends routine trough concentration monitoring within two distinct safety windows: 5.0 to 7.5 nanograms per milliliter for children with simple lesions or milder disease, and 8.0 to 10.2 nanograms per milliliter for those with complex or mixed vascular malformations, who may require higher exposure to achieve disease control.

The temporal dimension of the findings carries particular weight for families and clinicians committed to long-term therapy. Sirolimus treatment for vascular anomalies often continues for a year or more, and the study’s results indicate that vigilance must intensify rather than relax as months accumulate. Beyond six months of treatment, the authors call for heightened surveillance for myelosuppression and dyslipidemia through regular screening of blood counts and lipid panels. This is a meaningful departure from practice patterns in which monitoring may become less rigorous once a patient has tolerated the drug through the early treatment period.

Each of the three adverse reactions examined carries its own clinical stakes. Myelosuppression, the suppression of bone marrow activity, can lower blood cell counts and increase vulnerability to infection, anemia, and bleeding. Abnormal liver function signals hepatotoxicity that, if unchecked, can progress to more serious injury. Dyslipidemia, the elevation of blood lipids, is subtler but consequential in children, because lipid abnormalities established early in life can seed long-term cardiovascular risk. By quantifying how each toxicity relates to trough concentration, the framework allows clinicians to weigh these distinct risks against the therapeutic benefit of suppressing the malformation itself.

The broader significance of the work extends beyond vascular anomalies. Rare pediatric diseases pose a persistent methodological dilemma: patient populations are small, clinical trials are difficult to mount, and safety data are often fragmentary or anecdotal. The authors argue that their integrated framework offers a template for extracting rigorous, quantitative safety insights from the routine clinical data that even small cohorts generate. In doing so, the study addresses a genuine knowledge gap. Prior research had suggested a strong link between sirolimus exposure and adverse reactions, but the quantitative relationship, the actual probabilities of toxicity at given concentrations, had remained undefined, leaving clinicians to rely on empirical dosing inherited from transplant medicine.

Therapeutic drug monitoring itself is not new to sirolimus; the drug’s narrow therapeutic index has long demanded blood level measurement. What is new is the precision with which those measurements can now be interpreted. Instead of a single broad target range applied to every child, the study supports disease-specific and time-dependent target ranges, embedded within a predictive model that can forecast an individual patient’s exposure and toxicity risk before a dose is even administered. The retrospective design, approved by the Institutional Ethics Committee of Beijing Children’s Hospital, means the findings will need prospective validation, but the sample size and the density of pharmacokinetic sampling lend the conclusions substantial credibility.

For the children who depend on sirolimus to shrink lesions that compress airways, deform faces, or bleed unpredictably, the study promises something deceptively simple: a better chance of staying on the drug long enough for it to work. Treatment discontinuation driven by adverse reactions is one of the most common reasons vascular anomaly therapy fails, and every avoidable discontinuation represents a child whose disease resumes its advance. By converting pharmacological data into individualized risk estimates and dosing guidance, the BKMR-PopPK framework moves pediatric vascular anomaly care a decisive step closer to the era of precision medicine, where the question is no longer simply how much drug to give, but how much drug this particular child can safely carry.

Subject of Research: Quantifying sirolimus exposure-response safety relationships in pediatric vascular anomalies using an integrated BKMR-PopPK framework

Article Title: Safety of sirolimus in pediatric vascular anomalies: a BKMR-PopPK exposure–response framework for individualized risk and dosing

Article References: Liu, B., Xu, X.-L., Wang, J.-L., Li, J., Wu, Y.-X., Zhang, X.-X., Liu, Q.-Y., Zhao, Y.-M., Guo, P., Zhang, R.-Q., Zhou, H., Mao, X.-T., Jia, Y.-M., Cheng, X.-L., Wang, S.-C., & Wang, X.-L. (2026). Safety of sirolimus in pediatric vascular anomalies: a BKMR-PopPK exposure–response framework for individualized risk and dosing. World Journal of Pediatrics. https://doi.org/10.1007/s12519-026-01076-9

Image Credits: AI Generated

DOI: 10.1007/s12519-026-01076-9

Keywords: sirolimus, vascular anomalies, pediatrics, adverse drug reactions, therapeutic drug monitoring, population pharmacokinetics, Bayesian kernel machine regression, precision dosing, myelosuppression, dyslipidemia, liver function, rare diseases